United States · Investor

RTW Investments LLC

Last cheque observed Oct 2026; 87 cheques on record.

Deploying nowGrowth equity

Series BVentureSeries AInternetRide SharingBusiness Development

Deploying now
85%of best year33cheques in 12 months, 87 on record
Since the last cheque3days00hrs00min00sec
Median round$125MRounds led2 of 87Sole investor5 roundsMostly inUnited States, 84%
Pitch RTW Investments LLC

RTW Investments LLC highlights

  1. 01

    33 cheques in the last 12 months

  2. 02

    Mostly Series B and Venture: 54% of its rounds

  3. 03

    Sole investor in 5 rounds, median $108M

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
InternetRide SharingBusiness Development
Based in
New York, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first87 appearances

  1. 2026

    22 rounds

  2. Oct
    Zai LabCN · Pulse 2.0$250MWith 10 others
  3. Sept
    Pyxis OncologyUS$110MWith 4 others
  4. Jun
    MoonLake ImmunotherapeuticsCH$200MWith 2 others
  5. May
    Orchestra BioMedDebt · US$35MWith 1 other
  6. May
    OcugenDebt · US$115MWith 1 other
  7. May
    Whitehawk TherapeuticsUS$88MWith 2 others
  8. Apr
    Spyre TherapeuticsUS$403MWith 3 others
  9. Apr
    ImageneBioUS$30MWith 4 others
  10. Apr
    Oruka TherapeuticsUS$700MWith 3 others
  11. Apr
    GH ResearchIE$118MWith 4 others
  12. Mar
    Dianthus TherapeuticsUS$719MWith 3 others
  13. Mar
    SAB BiotherapeuticsUS$85MWith 3 others
  14. Mar
    Amani TherapeuticsSeries A · US$25MSole investor
  15. Mar
    ProliumSeries A · US$50MSole investor
  16. Feb
    EvommuneUS$125MWith 5 others
  17. Feb
    Immunic TherapeuticsUS$400MWith 5 others
  18. Jan
    Oricell TherapeuticsSeries C$70MWith 1 other
  19. Jan
    OcugenUS$23MWith 1 other
  20. Jan
    CORXEL PharmaceuticalsSeries D$287MWith 5 others
  21. Jan
    Monte Rosa TherapeuticsCH$300MWith 5 others
  22. Jan
    Mirador TherapeuticsSeries B · US$250MWith 6 others
  23. Jan
    Century TherapeuticsUS$135MWith 7 others
  24. 2025

    28 rounds

  25. Dec
    Kalaris TherapeuticsUS$50MWith 3 others
  26. Dec
    Kyverna TherapeuticsUS$100MWith 2 others
  27. Dec
    Jade BiosciencesUS$45MWith 4 others
  28. Dec
    Tenaya TherapeuticsUS$60MWith 3 others
  29. Dec
    Crescent BiopharmaUS$185MWith 4 others
  30. Dec
    Belite BioUS$350MWith 1 other
  31. Dec
    YarrowVenture · US$200MWith 3 others
  32. Nov
    Cogent BiosciencesDebt · US$200MWith 6 others
  33. Nov
    Verastem OncologyUS$90MWith 4 others
  34. Nov
    MoonLake ImmunotherapeuticsCH$75MWith 2 others
  35. Nov
    Artios PharmaSeries D · GB$115MWith 5 others
  36. Oct
    Kailera TherapeuticsSeries B · US · Crunchbase News$600MWith 9 others
  37. Oct
    Rapt TherapeuticsUS$250MWith 6 others
  38. Oct
    Biomea FusionUS$25MWith 2 others
  39. Oct
    Spyre TherapeuticsUS$275MWith 3 others
  40. Sept
    Mineralys TherapeuticsUS$288MWith 5 others
  41. Sept
    EnsomaVenture · US$53MWith 2 others
  42. Sept
    Oruka TherapeuticsUS$180MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration9 named

CJChristopher John SeiterChief Corporate Finance OfficeriForm ADV
DVDarshan Vishnu PatelChief Compliance OfficeriForm ADV
GMGotam MakkerPartner, Head of Strategic InvestmentsiForm ADV
NYNaveen YalamanchiPartner, Portfolio ManageriForm ADV
PMPeter M FongPartner, PresidentiForm ADV
RJRobert John AurigemaPartner, Chief Operating Officer and Chief Financial OfficeriForm ADV
RTRoderick Tze Ian WongManaging Partner, Chief Investment OfficeriForm ADV
SRSabera Reza LoughranPartner EmeritusiForm ADV
SAStephanie Anne SirotaPartner, Chief Business OfficeriForm ADV

We also hold 18 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$14Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
RTW Investments LP
SEC number
CRD 153232

Funds on its Form ADV

3 private funds, $8.4B in gross assets · filed Mar 2024

Hedge 2Private equity 1

  1. RTW Master Fund, LTD.Hedge1,418 investors$5.1B
  2. RTW Innovation Master Fund, LTD.Hedge349 investors$3.3B
  3. 4010 Royalty Investments ICAVPrivate equity35 investors$81M

Who they invest alongside

The investors most often in the same rounds as RTW Investments LLC. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies RTW Investments LLC put money into.

Quick answers about RTW Investments LLC

What does RTW Investments LLC invest in?

RTW Investments LLC invests most often at Series B and Venture (54% of the rounds on record), in sectors such as Internet, Ride Sharing and Business Development.

How active is RTW Investments LLC?

87 investments on record, 33 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.

What has RTW Investments LLC invested in recently?

Its most recent investments on record: Zai Lab (Undisclosed round, Oct 2026), Pyxis Oncology (Undisclosed round, Sept 2026) and MoonLake Immunotherapeutics (Undisclosed round, Jun 2026).

How big are RTW Investments LLC's cheques?

The median round it joins is $125M.

Does RTW Investments LLC lead rounds?

Sometimes: it led 2 of its 87 investments on record (2%).

Where does RTW Investments LLC invest?

Most of the companies it backs are in the United States (84%) and Switzerland (8%).

Is RTW Investments LLC investing now?

Yes: it is actively investing, with 33 investments in the last 12 months.

Who does RTW Investments LLC invest alongside?

Most often RA Capital Management (23 rounds together), Janus Henderson Investors (20 rounds together) and Cormorant Asset Management (18 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it